Teladoc Health Inc reports results for the quarter ended in March - Earnings Summary

• Teladoc Health Inc TDOC reported a quarterly adjusted loss of 49 cents​​ per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of -42 cents. The mean expectation of twenty seven analysts for the quarter was for a loss of 46 cents per share. Wall Street expected results to range from -54 cents to -28 cents per share.

• Revenue rose 2.7% to $646.13 million from a year ago; analysts expected $637.29 million.

• Teladoc Health Inc's reported EPS for the quarter was a loss of 49 cents​.

• The company reported a quarterly loss of $81.89 million.

• Teladoc Health Inc shares had fallen by 9.1% this quarter and lost 36.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 7.8% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 6 "strong buy" or "buy," 23 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the healthcare facilities & services peer group is also "hold"

Wall Street's median 12-month price target for Teladoc Health Inc is $18.00

This summary was machine generated from LSEG data April 25 at 11:16 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)